Is Acido pamidronico Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use Acido pamidronico? Is Acido pamidronico safe for nursing mother and child? Does Acido pamidronico extracts into breast milk? Does Acido pamidronico has any long term or short term side effects on infants? Can Acido pamidronico influence milk supply or can Acido pamidronico decrease milk supply in lactating mothers?

It is composed by bisphosphonates Most bisphosphonates are acidic compounds that achieve low plasma concentration. Both features make it unlikely excretion into the milk in clinically significant amount. Intestinal absorption of bisphosphonates is very low even during fasting and is considered negligible in the presence of milk due to formation with the calcium of non absorbable compounds. Acido pamidronico is excreted into breast milk in clinically insignificant amount and no problems have been observed in infants whose mothers were treated, except some cases of mild and asymptomatic hypocalcemia in infants whose mothers had been already treated before and / or during pregnancy, so some authors suggest regular monitoring of serum calcium.

Limited information indicates that maternal doses of Acido pamidronico of 30 mg intravenously produce very low levels in milk. Because Acido pamidronico has a serum half-life of about 3 hours, is highly bound to calcium and is poorly absorbed orally (0.3 to 3% in adults), absorption of Acido pamidronico by a breastfed infant is unlikely.[1] Until more data become available, withholding nursing for 12 to 24 hours after a dose should ensure that the breastfed infant is exposed to little or no Acido pamidronico. Other evidence indicates that breastfeeding after cessation of long-term Acido pamidronico treatment appears to have no adverse effects on the infant. Some experts recommend monitoring the infant's serum calcium during the first 2 months postpartum if the mother received Acido pamidronico during pregnancy or nursing.[2]

A mother received intravenous Acido pamidronico 30 mg once monthly beginning 6 months postpartum. She pumped her breasts and discarded the milk for 48 hours after each dose. The infant, who was about 80% breastfed throughout maternal Acido pamidronico therapy, remained healthy and grew normally during this time.[1] Because Acido pamidronico can persist in the body for years after long-term administration, the following cases may be relevant. Three women received Acido pamidronico intravenously for osteogenesis imperfecta or McCune-Albright syndrome in cumulative dosages of 6, 7.5 and 9 mg/kg annually for 2 years, 4 years, and 2.2 years, respectively. Their last doses were 3 months, 3 and 48 months (2 infants), and 21 months prior to conception, respectively. None of the women resumed Acido pamidronico during breastfeeding, but they all breastfed their infants postpartum, one for 18 months, two for undetermined times, and one for 6 weeks. None of the infants had any evidence of adverse effects of Acido pamidronico.[3] Two other mothers received intravenous Acido pamidronico infusions preconception and during pregnancy. On received a total of 240 mg with the final dose during the first trimester of pregnancy. She exclusively breastfed her infant for 6 months and continued breastfeeding until the infant was 12 months old. Her infant grew normally and had no adverse reactions.[4] Another woman received alendronate for 6 months, then Acido pamidronico every 4 months for 1 year prior to conception. Her infant was breastfed (extent not stated) for 3 months. The infant had mild hypocalcemia at 2 months of age, but a normal calcium level and normal long bone development at 5 months of age.[5] A woman developed transient osteoporosis with foot pain during pregnancy. On days 3 and 8 postpartum and 2 months later, she received 30 mg of Acido pamidronico intravenously. She was instructed to discard her breastmilk for 24 hours after each dose. Her breastfed (extent not stated) infant had normal growth and development at 15 months of age.[6]